Related Experiment Video
Updated: Jun 20, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
IL-21 is critical for GVHD in a mouse model
1Division of Hematology, Department of Medicine, Jichi Medical University Tochigi, Tochigi, Japan.
Interleukin-21 (IL-21) blockade significantly reduces graft-versus-host disease (GVHD) severity and mortality in mice. Blocking IL-21 signaling offers a potential new strategy for preventing GVHD after bone marrow transplantation (BMT).
Area of Science:
- Immunology
- Transplantation immunology
- Cellular immunology
Background:
- Interleukin-21 (IL-21) is known to affect T, B, and natural killer (NK) cells.
- The specific role of IL-21 in graft-versus-host disease (GVHD) is not well understood.
Purpose of the Study:
- To investigate the role of IL-21 in the pathogenesis of GVHD.
- To explore the potential of blocking IL-21 signaling as a strategy for GVHD prophylaxis.
Main Methods:
- Bone marrow transplantation (BMT) was performed using splenocytes from IL-21 receptor knockout (IL-21R(-/-)) mice and wild-type mice.
- A decoy receptor for IL-21 was generated and used to transduce bone marrow (BM) cells for BMT.
Main Results:
- Morbidity and mortality associated with GVHD were significantly reduced when using splenocytes from IL-21R(-/-) mice compared to wild-type mice.
- Mice receiving BM cells transduced with the IL-21 decoy receptor exhibited less severe GVHD compared to control groups.
Conclusions:
- IL-21 plays a critical role in regulating GVHD.
- Blocking the IL-21 signaling pathway presents a promising novel strategy for the prophylaxis of GVHD.
More Related Videos
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019